Admission to trading on AIM

Source: RNS
RNS Number : 5043B
Renold PLC
07 June 2019
 

Renold plc

("Renold", "the Company" or "the Group")

 

Admission of ordinary shares and preference stock to trading on AIM.

 

7 June 2019

 

Renold, a leading international supplier of industrial chains and related power transmission products, today announces that further to the Company's announcement on 11 April 2019 and the General Meeting held on 8 May 2019, the Board is pleased to confirm that the admission of the Company's ordinary shares of 5 pence each and the Company's units of 6 per cent. cumulative preference stock of £1.00 each (the "Entire Share Capital") to trading on AIM occured at 08.00 a.m. today, 7 June 2019.  The Entire Share Capital has been removed from trading on the Main Market of London Stock Exchange plc and the listings on the Official List have been cancelled.

 

Company information (as required by AIM Rule 26) can be found at www.investors.renold.com.

 

 

ENQUIRIES:

 

Renold plc 

0161 498 4500

Robert Purcell, Chief Executive


Ian Scapens, Group Finance Director




Peel Hunt LLP

020 7418 8900

Mike Bell

Ross Allister


Ed Allsopp






Instinctif Partners

020 7457 2020

Mark Garraway


Rosie Driscoll


 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AIMGMGGVNNFGLZG